BaseSpace
Correlation
Engine-Public
Sign In
Register
Correlation Engine 2.0
Home
My Data
Bookmarks
Collaborations
Inbox
Import Your Data
QuickView
FAQ
What is QuickView?
What can my QuickView results tell me?
What are the sources for the General Info tab in QuickView?
More QuickView FAQs
Back to top
QuickView
Curated
Studies
Body
Atlas
Disease
Atlas
Pharmaco
Atlas
Knockdown
Atlas
Genetic
Markers
Pathway
Enrichment
Literature
Clinical
Trials
0
Meta-
Analysis
QuickView
Search sequence regions
(e.g.
LEP
,
G-protein-coupled receptor binding
,
Pseudomonas infection
,
Prostate
,
Lipitor
)
Organisms
Chromosomes
Start
Stop
Homo Sapiens
Mus Musculus
Rattus Norvegicus
C. Elegans
D. Melanogaster
Saccharomyces Cerevisiae
QuickView
Go back to main search
Bookmark
Forward
QuickView
for
grades g3
(phenotype)
Summary
General Info
Genetic Markers
Most Correlated Genes
Most Correlated SNPs
NTRK2
SPARCL1
CXCL11
COL10A1
RGCC
No SNPs found
Explore Genetic Markers Results
Pathway Enrichment
Most Correlated Biogroups
cytosol
DODD_NASOPHARYNGEAL_CARCINOMA_DN
FISCHER_DREAM_TARGETS
PILON_KLF1_TARGETS_DN
cell periphery
Explore Pathway Enrichment Results
Curated Studies
Most Correlated Studies
Breast tumors with pathologic complete response (pCR) or residual disease (RD) upon chemotherapy
Breast carcinoma gene expression profiles distinguishing Her2+ and Her2- tumors
Endometrial tumor gene expression profiles associated with stage, grade, and histology
Invasive breast adenocarcinoma expression profiles
Non-neoplastic tissues adjacent to breast cancer expression profiles
Explore Curated Studies Results
Literature
Most Relevant Literature
Radioligand Therapy with [177Lu]Lu-DOTA-TATE or [177Lu]Lu-DOTA-TATE and [90Y]Y-DOTA-TATE in Patients…
Protective effect of sodium-glucose cotransporter 2 inhibitors in patients with rapid renal function…
Slope of the estimated glomerular filtration rate and its associated factors among individuals with …
Accuracy of the CUETO, EORTC 2016 and EAU 2021 scoring models and risk stratification tables to pred…
Risk factor analysis for a rapid progression of chronic kidney disease.
Explore Literature Results
Clinical Trials
Most Relevant Clinical Trials
Cabozantinib in Combination With Avelumab in Patients Refractory to Standard Chemotherapy With Advan…
Safety and Tolerability of Everolimus as Second-line Treatment in Poorly Differentiated Neuroendocri…
A Study of Anlotinib in Patients With Gastroenteropancreatic Neuroendocrine Tumor G3
Lenvatinib Plus Pembrolizumab in Well Differentiated G3 Neuroendocrine Tumors
Phase I Study GX-G3 in Healthy Subjects
Explore Clinical Trials Results
search
→
result
search
→
result
See more about this page
See complete FAQ